BioCardia, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Peter A. Altman, with a market cap of $10.4M.
Based on Q1 2026 filing
Common questions about BioCardia, Inc.
BioCardia, Inc. (BCDA) has a market capitalization of $10.4M and trades on NASDAQ.
BioCardia, Inc. has approximately 20 employees.